4//SEC Filing
Davis Todd C 4
Accession 0002001011-25-000050
CIK 0000886163other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 7:31 PM ET
Size
4.7 KB
Accession
0002001011-25-000050
Insider Transaction Report
Form 4
Davis Todd C
Director
Transactions
- Other
Common Stock
2025-06-30$91.08/sh+233$21,221→ 161,467 total
Footnotes (1)
- [F1]These shares were acquired under the Ligand Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Documents
Issuer
LIGAND PHARMACEUTICALS INC
CIK 0000886163
Entity typeother
Related Parties
1- filerCIK 0001392029
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 7:31 PM ET
- Size
- 4.7 KB